Qiao L, Koutsos M, Tsai L L, Kozoni V, Guzman J, Shiff S J, Rigas B
Department of Medicine, Cornell University Medical College, New York, NY 10021, USA.
Cancer Lett. 1996 Oct 1;107(1):83-9. doi: 10.1016/0304-3835(96)04346-7.
Staurosporine (ST), a potent inhibitor of protein kinase C (PKC), was evaluated for its effect on the proliferation of HT-29 colon adenocarcinoma cells; PKC is associated with increased colon cell proliferation. ST inhibited cell proliferation in a time- and concentration-dependent manner by up to 90%. It also blocked the G2/M phase of the cell cycle and induced classical apoptosis (sub-diploid peak on flow cytometry, DNA ladder, and typical morphological changes). The kinetics of these changes suggest that low ST concentrations (2-20 nM) may act via a different mechanism from higher (100-1000 nM) ones. The role of ST, which is currently evaluated as an antitumor agent, in colon cancer requires further evaluation.
